Literature DB >> 23878300

Re-examining racial disparities in prostate cancer outcomes.

Matthew R Cooperberg.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23878300     DOI： 10.1200/JCO.2013.50.7723

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

Review 1.  Epigenetic basis of cancer health disparities: Looking beyond genetic differences.

Authors:  Aamir Ahmad; Shafquat Azim; Haseeb Zubair; Mohammad Aslam Khan; Seema Singh; James E Carter; Rodney P Rocconi; Ajay P Singh
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-01-17       Impact factor: 10.680

2.  Putting Evidence Academies into action: Prostate cancer, nutrition, and tobacco control science.

Authors:  Karen Glanz; Sarah Green; Jade Avelis; Cathy L Melvin
Journal:  Prev Med       Date:  2019-11-05       Impact factor: 4.018

Review 3.  Role of Alternative Splicing in Prostate Cancer Aggressiveness and Drug Resistance in African Americans.

Authors:  Jacqueline Olender; Norman H Lee
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance.

Authors:  Jacqueline Olender; Bi-Dar Wang; Travers Ching; Lana X Garmire; Kaitlin Garofano; Youngmi Ji; Tessa Knox; Patricia Latham; Kenneth Nguyen; Johng Rhim; Norman H Lee
Journal:  Mol Cancer Res       Date:  2019-07-02       Impact factor: 5.852

5.  Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management.

Authors:  Scott P Kelly; Stephen K Van Den Eeden; Richard M Hoffman; David S Aaronson; Tania Lobo; George Luta; Amethyst D Leimpter; Jun Shan; Arnold L Potosky; Kathryn L Taylor
Journal:  J Urol       Date:  2016-04-14       Impact factor: 7.450

Review 6.  Racial disparities in prostate cancer: a molecular perspective.

Authors:  Arun Bhardwaj; Sanjeev K Srivastava; Mohammad Aslam Khan; Vijay K Prajapati; Seema Singh; James E Carter; Ajay P Singh
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

7.  Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer.

Authors:  Yu Liu; Ingrid J Hall; Christopher Filson; David H Howard
Journal:  Urol Oncol       Date:  2020-12-09       Impact factor: 2.954

8.  Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer.

Authors:  Eric T Miller; Karim Chamie; Lorna Kwan; Michael S Lewis; Beatrice S Knudsen; Isla P Garraway
Journal:  Cancer Med       Date:  2016-12-20       Impact factor: 4.452

9.  Profiles of miRNA Isoforms and tRNA Fragments in Prostate Cancer.

Authors:  Rogan G Magee; Aristeidis G Telonis; Phillipe Loher; Eric Londin; Isidore Rigoutsos
Journal:  Sci Rep       Date:  2018-03-28       Impact factor: 4.379

10.  Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer.

Authors:  S Halabi; S Dutta; C M Tangen; M Rosenthal; D P Petrylak; I M Thompson; K N Chi; J S De Bono; J C Araujo; C Logothetis; M A Eisenberger; D I Quinn; K Fizazi; M J Morris; C S Higano; I F Tannock; E J Small; W K Kelly
Journal:  Ann Oncol       Date:  2020-04-11       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.